NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of SB One Bancorp SBBX, Tetraphase Pharmaceuticals, Inc. TTPH, AVX Corporation AVX, and Front Yard Residential Corporation RESI. Additional information about each potential action can be found at the link provided.
SB One Bancorp SBBX
Buyer: Provident Financial Services
On March 12, 2020 SB One announced that it had signed an agreement to be acquired by Provident for approximately $208.9 million. Per the merger agreement SB One's stockholders will receive 1.357 shares of Provident common stock for each share of SB One common stock owned. The deal is scheduled to close in the third quarter of 2020.
Bragar Eagel & Squire is concerned that SB One's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for SB One's stockholders.
To learn more about the SBBX investigation go to: https://bespc.com/sbbx/.
Tetraphase Pharmaceuticals, Inc. TTPH
Buyer: AcelRx Pharmaceuticals
On March 16, 2020 Tetraphase announced that it had signed an agreement to be acquired by AcelRx for approximately $14.4 million plus a contingent value right (CVR) worth up to $12.5 million if XERAVA reaches certain net sales milestones starting in 2021. Per the merger agreement Tetraphase's stockholders will receive 0.6303 shares of AcelRx common stock plus their share of the CVR for each share of Tetraphase common stock owned. The deal is scheduled to close in the second quarter of 2020.
Bragar Eagel & Squire is concerned that Tetraphase's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Tetraphase's stockholders.
To learn more about Tetraphase investigation go to: https://bespc.com/ttph-2/.
AVX Corporation AVX
Buyer: Kyocera Corporation
On February 21, 2020 AVX announced that it had signed an agreement to merge with Kyocera. Per the merger agreement AVX stockholders will receive $21.75 in cash for each share of AVX common stock owned. The deal is scheduled to close in the fourth quarter of 2020.
Bragar Eagel & Squire is concerned that AVX's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for AVX stockholders.
To learn more about the AVX investigation go to: https://bespc.com/avx/.
Front Yard Residential Corporation RESI
Buyer: Amherst Residential, LLC
On February 18, 2020 Front Yard announced that it had signed an agreement to merge with Amherst Residential. Per the merger agreement Front Yard stockholders will receive $12.50 in cash for each share of Front Yard common stock owned. The deal is scheduled to close in the second quarter of 2020.
Bragar Eagel & Squire is concerned that Front Yard's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Front Yard stockholders.
To learn more about the Front Yard investigation go to: https://bespc.com/resi/.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Alexandra Raymond, Esq.
investigations@bespc.com
www.bespc.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
